UCSF Researchers Fingerprint Lung Tumors, Test New Drug Candidate
Our own Dr. David Jablons made the LungBlog today. Adding their own contributions to a rapidly advancing field, UCSF researchers - along with colleagues from Incyte Corporation and the University of Texas Southwestern Medical Center - have described new targets in lung cancer and evaluated a promising new drug candidate that halts growth signals in tumor cells grown in the lab.
This entry was posted on Friday, July 28th, 2006 at 8:51 am and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.